ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Perioperative Cardiovascular Outcomes of Pre-Transplant ECMO in Recipients of Lung Transplant

F. Anjum1, R. Munshi2, A. M. Courtwright1, M. M. Crespo1, J. C. Salgado1, J. D. Christie1, V. N. Ahya1, N. Patel1, D. Hadjiliadis1, E. Clausen1, M. Cevasco3, E. E. Cantu3, C. A. Bermudez3, J. M. Diamond1

1Pulmonary and Critical Care, University of Pennsylvania, Philadelphia, PA, 2Nassau University Medical Center, East Meadow, NY, 3Cardiovascular Surgery, University of Pennsylvania, Philadelphia, PA

Meeting: 2022 American Transplant Congress

Abstract number: 1482

Keywords: Lung transplantation, Outcome

Topic: Clinical Science » Lung » 64 - Lung: All Topics

Session Information

Session Name: Lung Transplantation

Session Type: Poster Abstract

Date: Monday, June 6, 2022

Session Time: 7:00pm-8:00pm

 Presentation Time: 7:00pm-8:00pm

Location: Hynes Halls C & D

Session Information

Session Name: Poster Chat: Heart and Lung

Session Type: Poster Chat

Date: Tuesday, June 7, 2022

Session Time: 7:00pm-8:00pm

 Presentation Time: 7:00pm-8:00pm

Location: Hynes Hall C

*Purpose: Use of extracorporeal membrane oxygenation (ECMO) as a bridge to lung transplant (BTT) has increased over time. While similar one-year and overall survival has been reported compared to non- ECMO BTT recipients, there is limited data on other outcomes in this population including major adverse cardiovascular and cerebrovascular events (MACCE) and bleeding events. We sought to evaluate the incidence of perioperative MACCE and major bleeding events in patients undergoing ECMO BTT.

*Methods: Using the National Inpatient Sample from 2008 to 2019, we identified 5254 lung transplant recipients. We then compared baseline characteristics and in-hospital outcomes between patients who underwent ECMO BTT vs. non-ECMO BTT. Using logistic regression, in-hospital outcomes were adjusted for diagnosis, Charlson Comorbidity Index, cardiovascular risk factors, age, gender, and race. The primary outcomes were perioperative MACCE, defined as in-hospital death, myocardial infarction (MI), cardiogenic shock or ischemic stroke, and major bleeding event requiring blood transfusion or surgical intervention post-transplant including hemothorax, hemoperitoneum, hemopericardium, pulmonary hemorrhage, intracranial bleed, gastrointestinal and post-operative skin hemorrhage.

*Results: Perioperative MACCE occurred in 738(14%) lung transplant surgeries while major bleeding occurred in 717(13.64%) patients in the overall cohort. ECMO BTT patients had a higher incidence of MACCE compared to non-BTT (13% vs. 35%, p <0.0001) as well as major bleeding events (12% vs 34%, p <0.0001). Recipients of pre-transplant ECMO for double lung transplant (n=158), were more likely to have perioperative MACCE and major bleeding events in comparison to patients without pre-transplant ECMO (n=3584) [adjusted odds ratio (aOR) 2.69, P <0.0001; 95% Confidence interval [CI] 1.86-3.80].

*Conclusions: ECMO BTT recipients are at an increased odds of MACCE and major bleeding. Close post-operative monitoring and detailed pre-operative risk assessment is warranted in the ECMO BTT population to allow for risk mitigation, prompt diagnosis and early intervention for MACCE and major bleeding complications.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Anjum F, Munshi R, Courtwright AM, Crespo MM, Salgado JC, Christie JD, Ahya VN, Patel N, Hadjiliadis D, Clausen E, Cevasco M, Cantu EE, Bermudez CA, Diamond JM. Perioperative Cardiovascular Outcomes of Pre-Transplant ECMO in Recipients of Lung Transplant [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/perioperative-cardiovascular-outcomes-of-pre-transplant-ecmo-in-recipients-of-lung-transplant/. Accessed May 30, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences